Peripheral Stent Implants Market

 Global Peripheral Stent Implants Market Forecast

The Peripheral Stent Implants Market is expected to grow from USD 4.2 Billion in 2026 to USD 6.6 Billion by 2033, reflecting strong industry expansion and registering a CAGR of 6.7% during the forecast period from 2026 to 2033.

The market analysis shows rapid growth in the coming years. The market registered a historic CAGR of 5.6% from 2015 to 2022. The market is expected to reach a valuation of US$3.9 Bn in 2024, with a CAGR of 7.60%. Over 230 million people worldwide suffer from PAD. The demand for stents and longer life expectancies in the geriatric population has created opportunities for manufacturers. Advancements in radiotherapy, gene therapy, imaging technology, and implementation have expanded treatment options for PAD, including balloon angioplasty, excisional atherectomy, and drug-eluting technologies.  

As per the Fairfield’s analysis, the peripheral stent implants market is projected to surpass US$7.1 Bn by 2031, with a CAGR of 8.90%. The market is expected to grow due to its low treatment risk, cost-effectiveness, and faster recovery time. Manufacturers can focus on developing innovative reabsorbable stents and peripheral local drug delivery for restenosis treatment. Further, cost-effective endovascular treatments are becoming more popular, and the longevity of these treatments contributes to increased surgeries. Outpatient reimbursement policies and growing end users in developing countries further fuel the market. 

• Increasing Prevalence of Peripheral Artery Disease (PAD)

The rise in the prevalence of peripheral diseases, the increase in the geriatric population, and the launch of advanced products are expected to drive market growth. The rising prevalence of PAD is expected to increase the demand for peripheral stents, boosting market growth. The elderly population, more prone to developing peripheral vascular diseases, is expected to drive the market growth.

Peripheral artery disease is a common vascular condition that affects the arteries outside the heart and brain. The rising prevalence of PAD, particularly among the aging population, is expected to drive the peripheral stent implants market demand. As the population ages and the incidence of diabetes and obesity increases, the number of patients with PAD is also expected to rise. This, in turn, will lead to an increased demand for stents to treat blocked or narrowed arteries and improve blood flow to the extremities.

• Technological Advancements in Stent Design and Materials

Technological advancements in stent design and materials have significantly improved the safety and efficacy of peripheral stent implants. The development of drug-eluting stents, which release medication to prevent restenosis (re-narrowing of the artery), has revolutionized the treatment of peripheral artery disease. These advancements have led to better patient outcomes, reduced rates of revascularization procedures, and increased adoption by healthcare providers.

Additionally, the introduction of bioresorbable stents that gradually dissolve over time offers a promising alternative to traditional metallic stents. All these advancements are fueling the peripheral stent implants market expansion.

• Growing Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive procedures among patients and healthcare providers. Minimally invasive procedures offer several advantages, including shorter hospital stays, faster recovery times, and reduced risk of complications. Peripheral stent implants, which can be placed using minimally invasive techniques such as angioplasty, are increasingly preferred over open surgical procedures. The demand for these procedures is expected to drive the market revenue as more healthcare facilities invest in the necessary equipment and training to perform these interventions.

• Stringent Regulatory Approval Process

According to the peripheral stent implants market analysis, the regulatory approval process for medical devices can be lengthy and complex. Regulatory bodies, such as the FDA, require extensive clinical trials and evidence of safety and efficacy before granting approval for market entry. This rigorous process can significantly delay the introduction of new stent products into the market.

Additionally, the cost associated with obtaining regulatory approvals can be substantial, especially for smaller companies with limited resources. These factors can act as barriers to entry for new industry players and hinder the overall market growth.

• Impact of COVID-19 Pandemic

The market research report shows the COVID-19 pandemic has had a significant impact on the healthcare industry, and so on the industry. The prioritization of COVID-19-related diagnostic and treatment devices over cardiovascular procedures has led to a decrease in the number of elective procedures, including those related to peripheral stent implants.

Many surgical facilities and hospitals have considered canceling or delaying non-urgent procedures, which has affected the market growth to a certain extent. The operational and clinical difficulties faced by healthcare facilities during the pandemic have also contributed to the slowdown in peripheral stent implants market sales.

• Increasing Adoption of Bio-absorbable Stents

One of the significant market trends is the increasing adoption of bio-absorbable stents. Bio-absorbable stents are designed to gradually degrade and be absorbed by the body over time, eliminating the need for a permanent metallic implant. These stents are made from materials such as polylactic acid (PLA) or polyglycolic acid (PGA), which are biocompatible and biodegradable.

The trend towards bio-absorbable stents is driven by several factors. They offer potential benefits in terms of reducing the risk of long-term complications associated with permanent metallic stents, such as in-stent restenosis or late thrombosis. Bio-absorbable stents may allow for better vessel healing and restoration of natural vessel function after the stent has dissolved. They also provide an alternative treatment option for patients who may require future interventions or have complex anatomies that make the use of permanent stents challenging.

Further, industry news shows that the adoption of bio-absorbable stents is supported by ongoing research and development efforts to improve their performance and safety. Manufacturers are investing in clinical trials and studies to evaluate the long-term outcomes and effectiveness of these stents. Additionally, regulatory bodies are actively involved in assessing the safety and efficacy of bio-absorbable stents and providing guidelines for their use. The increasing adoption of bio-absorbable stents represents a significant trend in the peripheral stent implants market, driven by the potential benefits they offer in terms of patient outcomes and long-term vessel health.

• Growing Market Potential in India, and China

As per the peripheral stent implant market overview, India, and China present significant opportunities for investors and stakeholders in the peripheral stent implant industry. These countries have large populations and a rising prevalence of PAD due to factors such as changing lifestyles, increasing rates of diabetes and obesity, and an aging population.

In India, the demand is expected to grow due to the increasing burden of PAD and the improving healthcare infrastructure. The Indian government has also taken initiatives to promote the use of advanced medical devices, including stents, by implementing price controls and streamlining regulatory processes. On the other hand, China offers lucrative peripheral stent implants market opportunities. The country has a large patient pool and a growing awareness of cardiovascular diseases. The Chinese government has implemented policies to improve healthcare access and affordability, which is expected to drive the demand.

How is Regulatory Scenario Shaping this Industry?

The regulatory scenario for the market growth is an important aspect that shapes the market landscape. The FDA plays a crucial role in regulating medical devices, including stents. They have specific guidelines and requirements for the approval and marketing of stents. According to the market update, regulatory bodies are focused on ensuring the safety and efficacy. They require manufacturers to adhere to specific standards and conduct non-clinical engineering tests to demonstrate the device's ability to withstand external loads and deformations.

The expansion of 3D printing technology has introduced unique regulatory challenges for device design, development, manufacturing, biocompatibility, and sterilization. The FDA is actively involved in developing consensus strategies for validating 3D-printed medical devices. The peripheral stent implants market players are investing in research and development activities to launch low-cost peripheral artery stents and develop effective products that simplify interventional procedures. These efforts are aimed at meeting the demands posed by rising peripheral artery disease.

Segments Covered in Peripheral Stent Implants Market Report

• Bare Metal Stents Dominate as Non-invasive Procedures Gain Traction

Bare metal stents accounted for a significant 75.9% share of the global market in 2022. These stents are highly favored due to their non-invasive nature and local anesthetic procedures. The peripheral stent implants market value is further driven by the development of bioresorbable stents and the growing number of cath labs. Among the bare metal stents segment, the balloon expandable stent is the preferred choice, offering higher radial stiffness and precise placement. These stents have demonstrated success in reducing restenosis and vessel closure, resulting in lower rates of target lesion revascularization (TLR).

• Iliac Artery Stents Take the Steer Through Technological Advancements

Iliac artery stents accounted for approximately 47% of the total peripheral stent implants market share in 2022, driven by various factors. The increasing global incidence of atherosclerosis and cardiovascular diseases is a primary driver for the growing demand for iliac artery stents. Additionally, rapid technological advancements and the widespread acceptance of stenting procedures among patients contribute to the rising demand for these stents. Furthermore, the growing geriatric population and the rising preference for minimally invasive surgeries further fuel the demand for iliac artery stents.

• Hospitals Dominate the Market as are Established to Offer Efficient Treatments

As per the peripheral stent implants market update, hospitals accounted for a significant market share of approximately 58.4% in 2022. The hospital segment emerged as the largest contributor by end user and is projected to maintain its leadership position in the forecast period. This can be attributed to several factors, including a growing number of patients choosing hospitals for angioplasty procedures, an increasing prevalence of coronary artery diseases, government initiatives to enhance medical infrastructure, rising awareness about disease treatment and management, and a rise in sedentary lifestyles.

• North America Surges Ahead of All, Led by US

As per the market forecast, the US held a significant market share of approximately 46.2% in 2022, driven by the increasing prevalence of peripheral artery disease in the country. Factors contributing to this prevalence include higher rates of smoking, sedentary lifestyles, poor dietary choices, cerebral and cardiovascular diseases, diabetes, and a large geriatric population.

According to the Centers for Disease Control and Prevention, an estimated 6.5 million individuals aged 40 and older in the US are projected to have PAD by 2022. The availability of drug-eluting stents and favorable medical reimbursement policies further propel the growth of the peripheral stent implants market.

• Germany at the Forefront of Market Growth in Europe, Set to Gain from Rising PAD Prevalence

Germany accounted for approximately 4.3% of the global market share in 2022. The growth of the stents market in Germany is driven by several factors, including the increasing prevalence of PAD, a preference for non-invasive stent procedures, and investments in the development of advanced stents by both the private and public sectors.

Additionally, the rising prevalence of obesity, an increase in percutaneous coronary intervention (PCI) operations, and high demand for minimally invasive surgeries (MIS) contribute to the peripheral stent implants market growth. The introduction of advanced drug-eluting stents (DES), the development of bioresorbable scaffolds, and the rise in cardiovascular illnesses (CVDs) also impact the market.

The competitive landscape of the peripheral stent implants market concentration is characterized by the presence of several key players. These companies are recognized as key players in the peripheral stent implant market growth and are actively involved in the research, development, and manufacturing of stents. They have a significant market presence and contribute to the growth and innovation of the industry.

Key Market Companies

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Biotronik SE & Co. KG
• Cook Medical, Inc.
• Terumo Corporation
• B. Braun Melsungen AG
• Cordis Corporation
• W. L. Gore & Associates, Inc.
• iVascular SLU

Product Type